Abstract
Tumoral thymidine phosphorylase (TP) appears to play a dual role by being involved in neoangiogenesis and by activating 5FU prodrugs at the tumoral target site. The aim of the study was to investigate more thoroughly these potential physiological and pharmacological roles of TP. A rat carcinoma cell line (PROb) was transfected with TP/PD-ECGF in order to study the effect of the overexpression of this enzyme (1) on the sensitivity of cells to 5′DFUR and 5FU in vitro and (2) on tumour growth in vivo by using a syngenic tumour model in the BDIX rat (hepatic tumours, sub-cutaneous tumours). Cytotoxic effects of 5'DFUR, and to a lesser extent those of 5FU, were enhanced in TP clones as compared to control cells: there was a highly significant correlation between TP activity and in vitro sensitivity to 5'DFUR (r2= 0.91, P = 0.0002, n = 8) and, to a lesser extent, to 5FU (r2= 0.49, P = 0.053, n = 8). The impact of TP transfection on tumour growth was relatively modest and concerned only the initial stages of tumour expansion. Staining of TP tumours for endothelial (factor VIII) cells was always higher than controls. The staining ratio (TP/controls) tended to be reduced as tumours increased in size. The stability of TP expression was checked both in vitro (TP activity measurement) and in vivo (RT-PCR determinations) and there was no loss of TP expression over time which could be advanced to explain the progressive weakening of the impact of TP overexpression on both tumour growth and neoangiogenesis. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Auerbach R, Morrissey LW and Sidki YA (1978) Regional differences in the incidence and growth of mouse tumors following intradermal or sub-cutaneous inoculation. Cancer Res 38: 1739–1744
Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein using the principle of protein dye binding. Anal Biochem 72: 248–254
Brown NS and Bicknell R (1998) Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J 334: 1–8
Brown NS, Jones A, Fujiyama C, Harris A and Bicknell R (2000) Thymidine phosphorylase induces carcinoma cell oxicative stress and promotes secretion of angiogenic factors. Cancer Res 60: 6298–6302
Budman DR, Meropol NJ, Reigner B, Creaven PJ, Lichtman SM, Berghorn E, Behr J, Gordon RJ, Osterwalder B and Griffin T (1998) Preliminary studies of a novel fluoropyrimidine carbonate: capecitabine. J Clin Oncol 16: 1795–1802
Caignard A, Martin MS, Michel MF and Martin F (1985) Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host. Int J Cancer 36: 273–279
Carmichael J, De Graff WG and Gazdar AF (1987) Evaluation of a tetrazolium-based semi-automated colonimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936–941
Ciccolini J, Paillard L, Evrard A, Cuq P, Aubert C, Pelegrin A, Formento P, Milano G and Catalin J (2000) Enhanced antitumor activity of 5-fluourouracil in combination with 2′-deoxyinosine in human colorectal cell lines and human colon tumor xenografts. Clin Cancer Res 6: 1529–1535
Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K and Ishitsuka H (1993) Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′DFUR. Cancer Chemother Pharmacol 32: 333–338
Evrard A, Cuq P, Robert B, Vian L, Pelegrin A and Cano JP (1999) Enhancement of 5-fluorouracil cytotoxicity by human thymidine phosphorylase expression in cancer cells: in vitro and in vivo study. Int J Cancer 80: 465–470
Folkman J (1996) What is the role of thymidine phosphorylase in tumor angiogenesis?. J Natl Cancer Inst 88: 1091–1092
Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC and Harris AL (1995) Platelet-derived endothelial cell growth factor thymidine phosphorylase expression in normal tissues – an immunohistochemical study. J Pathol 176: 183–190
Fox SB, Westwood M, Mogghadam A, Comley M, Turley H, Whitehouse RM, Bicknell R, Gatter KC and Harris AL (1996) The angiogenic factor, platelet-derived endothelial cell growth factor thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 73: 275–280
Giatromanolaki A, Fountzilas G, Koukourakis MI, Arapandoni P, Theologi V, Kakolyris S, Georgoulias V, Harris AL and Gatter KC (1998) Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation. Clin Exp Metastasis 16: 665–672
Igarashi M, Kumar Dhar D, Kubota H, Yamamoto A, El Assal O and Nagasue N (1998) The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the oesophagus. Cancer 82: 1225–1232
Imazono Y, Takebayashi Y, Nishiyama K, Akiba S, Miyadera K, Yamada Y, Akiyama S and Ohi Y (1997) Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 15: 2570–2578
Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W and Heldin C-H (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557–562
Ishikawa T, Sekiguchi F, Fukase Y, Sawada N and Ishitsuka H (1998) Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res 58: 685–690
Kato Y, Matzuhawa S, Murooka R and Tanigawa N (1997) Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA. Br J Cancer 75: 506–511
Kubota Y, Miura T, Moriyanna M, Noguchi S, Matsuzaki J, Takebayashi S and Hosaka M (1997) Thymidine phosphorylase activity in human bladder cancer: difference between superficial and invasive cancer. Clinical Cancer Res 3: 973–976
Maeda K, Kang SM, Ogawa M, Onada N, Sawada T, Nakata B, Kato Y, Chung YS and Sowa M (1997) Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma. Int J Cancer 74: 545–550
Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimoti K, Akiba S, Miyadeva K, Fukushima M, Yamada Y, Yoshida H, Kenzaki T and Akiyama S (1999) The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res 59: 1911–1916
Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y and Akiyama S (1995) Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 55: 1687–1690
Moghaddam A and Bicknell R (1992) Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31: 12141–12146
Moghaddam A, Zhang HT, Fan TPD, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL and Bicknell R (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 82: 998–1002
O'Brien T, Cranston D, Fuggle S, Bicknell R and Harris AL (1995) Different angiogenic pathways characterise superficial and invasive bladder cancer. Cancer Res 55: 510–513
Patterson AV, Zhang H, Moghoddam A, Bicknell R, Talbot DC, Stratford IJ and Harris AL (1995) Increased sensitivity to the prodrug 5′-deoxy-5- fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 72: 669–675
Sawada N, Ishikawa T, Fukase Y, Nishida M, Yoshikubo T and Ishitsuka H (1998) Induction of Thymidine Phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts. Clin Cancer Res 4: 1013–1019
Schwartz EL, Baptiste N, Wodler S and Makower D (1995) Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J Biol Chem 270: 19073–19077
Shaw T, Smillie RH and MacPhee DG (1988) The role of blood platelets in nucleoside metabolism: assay, cellular location and significance of thymidine phosphorylase in human blood. Mutat Res 200: 99–116
Takebayashi Y, Miyadera K, Kakiyama S, Hokita S, Yamada K, Akiba S, Yamada Y, Sumizawa T and Aikou T (1996a) Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 87: 288–295
Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F and Aikou T (1996b) Clinicophathological and prognostic significance of an angiogenic growth factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110–1117
Takebayashi TG, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, Aoki D, Okumura H, Yamada Y, Akiyama S and Aikou T (1996) The activity and expression of thymidine phosphorylase in human solid tumors. Eur J Cancer 32: 1227–1232
United Kingdom Co-ordinating Committee on Cancer Research(UKCCCR) (1998) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). Br J Cancer 77: 1–10
Zimmerman M and Seidenberg J (1964) Deoxyribosil transfer. J Biol Chem 239: 2618–2621
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Marchetti, S., Chazal, M., Dubreuil, A. et al. Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis. Br J Cancer 85, 439–445 (2001). https://doi.org/10.1054/bjoc.2001.1908
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1908
This article is cited by
-
Genetic factors influencing Pyrimidine-antagonist chemotherapy
The Pharmacogenomics Journal (2005)
-
Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration
Journal of Cancer Research and Clinical Oncology (2005)
-
Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity
British Journal of Cancer (2003)